Exscientia Q1 EPS $(0.38) Beats $(0.43) Estimate, Sales $7.10M Miss $8.03M Estimate
Portfolio Pulse from Benzinga Newsdesk
Exscientia (NASDAQ:EXAI) reported Q1 EPS of $(0.38), beating the $(0.43) estimate, but sales of $7.10M missed the $8.03M estimate. This represents a 7.32% increase in EPS and a 22.83% decrease in sales compared to the same period last year.
May 24, 2023 | 11:01 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Exscientia's Q1 EPS beat estimates, but sales missed expectations, showing mixed financial performance.
Exscientia's Q1 earnings show a mixed financial performance, with EPS beating estimates by 11.63% but sales missing by 11.58%. This may lead to a neutral short-term impact on the stock price, as investors weigh the positive EPS result against the negative sales performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100